These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24661151)

  • 1. Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis.
    Patntirapong S; Singhatanadgit W; Arphavasin S
    J Clin Pharm Ther; 2014 Aug; 39(4):349-53. PubMed ID: 24661151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.
    Duque G; Rivas D
    J Bone Miner Res; 2007 Oct; 22(10):1603-11. PubMed ID: 17605634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
    Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
    J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model.
    Park KW; Yun YP; Kim SE; Song HR
    Int J Mol Sci; 2015 Nov; 16(11):26738-53. PubMed ID: 26561810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.
    Wang CZ; Chen SM; Chen CH; Wang CK; Wang GJ; Chang JK; Ho ML
    Biomaterials; 2010 Nov; 31(33):8674-83. PubMed ID: 20719378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alendronate soaking and ultraviolet treatment on bone-implant interface.
    Kim HS; Lee JI; Yang SS; Kim BS; Kim BC; Lee J
    Clin Oral Implants Res; 2017 Sep; 28(9):1164-1172. PubMed ID: 27458172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.
    Kim HK; Kim JH; Abbas AA; Yoon TR
    Clin Orthop Relat Res; 2009 Dec; 467(12):3121-8. PubMed ID: 18665432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
    Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
    J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX).
    Roschger P; Lombardi A; Misof BM; Maier G; Fratzl-Zelman N; Fratzl P; Klaushofer K
    J Bone Miner Res; 2010 Jan; 25(1):48-55. PubMed ID: 19580465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial administration of rhBMP-2 and alendronate enhances the differentiation of osteoblasts.
    Kim SH; Choi HJ; Yoon DS; Son CN
    Int J Rheum Dis; 2021 Oct; 24(10):1266-1272. PubMed ID: 34324274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinational effect of matrix elasticity and alendronate density on differentiation of rat mesenchymal stem cells.
    Jiang P; Mao Z; Gao C
    Acta Biomater; 2015 Jun; 19():76-84. PubMed ID: 25805109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control over the gradient differentiation of rat BMSCs on a PCL membrane with surface-immobilized alendronate gradient.
    Zhu Y; Mao Z; Gao C
    Biomacromolecules; 2013 Feb; 14(2):342-9. PubMed ID: 23231431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells.
    Chang CH; Wang CZ; Chang JK; Hsu CY; Ho ML
    PLoS One; 2014; 9(8):e105705. PubMed ID: 25157615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.
    Lindtner RA; Tiaden AN; Genelin K; Ebner HL; Manzl C; Klawitter M; Sitte I; von Rechenberg B; Blauth M; Richards PJ
    Osteoporos Int; 2014 Mar; 25(3):1151-61. PubMed ID: 23974861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells.
    Xiong Y; Yang HJ; Feng J; Shi ZL; Wu LD
    J Int Med Res; 2009; 37(2):407-16. PubMed ID: 19383235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro.
    Zhang L; Zhang J; Ling Y; Chen C; Liang A; Peng Y; Chang H; Su P; Huang D
    J Pineal Res; 2013 Jan; 54(1):24-32. PubMed ID: 22712496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages inhibit migration, metabolic activity and osteogenic differentiation of human mesenchymal stem cells in vitro.
    Chen C; Uludağ H; Wang Z; Rezansoff A; Jiang H
    Cells Tissues Organs; 2012; 195(6):473-83. PubMed ID: 22156615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells.
    Alasmari A; Lin SC; Dibart S; Salih E
    Clin Exp Metastasis; 2016 Aug; 33(6):563-88. PubMed ID: 27155840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylserine enhances osteogenic differentiation in human mesenchymal stem cells via ERK signal pathways.
    Xu C; Zheng Z; Fang L; Zhao N; Lin Z; Liang T; Zhai Z; Zhou J
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1783-8. PubMed ID: 23827636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.